Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Sexually Transmitted Diseases (STDs) Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Chlamydia
      • 1.3.3 Gonorrhea
      • 1.3.4 Syphilis
      • 1.3.5 Genital herpes
      • 1.3.6 HPV
      • 1.3.7 HIV / AIDS
    • 1.4 Market Segment by Application
      • 1.4.1 Global Sexually Transmitted Diseases (STDs) Drug Market Share by Application (2019-2025)
      • 1.4.2 Hospital Pharmacies
      • 1.4.3 Retail Pharmacies
      • 1.4.4 Online Pharmacies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Sexually Transmitted Diseases (STDs) Drug Market Size
      • 2.1.1 Global Sexually Transmitted Diseases (STDs) Drug Revenue 2014-2025
      • 2.1.2 Global Sexually Transmitted Diseases (STDs) Drug Sales 2014-2025
    • 2.2 Sexually Transmitted Diseases (STDs) Drug Growth Rate by Regions
      • 2.2.1 Global Sexually Transmitted Diseases (STDs) Drug Sales by Regions 2014-2019
      • 2.2.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers
      • 3.1.1 Sexually Transmitted Diseases (STDs) Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Sexually Transmitted Diseases (STDs) Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Sexually Transmitted Diseases (STDs) Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Sexually Transmitted Diseases (STDs) Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Sexually Transmitted Diseases (STDs) Drug Price by Manufacturers
    • 3.4 Key Manufacturers Sexually Transmitted Diseases (STDs) Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Sexually Transmitted Diseases (STDs) Drug Market
    • 3.6 Key Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Chlamydia Sales and Revenue (2014-2019)
      • 4.1.2 Gonorrhea Sales and Revenue (2014-2019)
      • 4.1.3 Syphilis Sales and Revenue (2014-2019)
      • 4.1.4 Genital herpes Sales and Revenue (2014-2019)
      • 4.1.5 HPV Sales and Revenue (2014-2019)
      • 4.1.6 HIV / AIDS Sales and Revenue (2014-2019)
    • 4.2 Global Sexually Transmitted Diseases (STDs) Drug Sales Market Share by Type
    • 4.3 Global Sexually Transmitted Diseases (STDs) Drug Revenue Market Share by Type
    • 4.4 Sexually Transmitted Diseases (STDs) Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Sexually Transmitted Diseases (STDs) Drug Sales by Application

    6 United States

    • 6.1 United States Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Company
    • 6.2 United States Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Type
    • 6.3 United States Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Company
    • 7.2 European Union Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Type
    • 7.3 European Union Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Application

    8 China

    • 8.1 China Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Company
    • 8.2 China Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Type
    • 8.3 China Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Company
    • 9.2 Rest of World Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Type
    • 9.3 Rest of World Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Application
    • 9.4 Rest of World Sexually Transmitted Diseases (STDs) Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Sexually Transmitted Diseases (STDs) Drug Sales by Countries
      • 9.4.2 Rest of World Sexually Transmitted Diseases (STDs) Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.1.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Hoffmann La Roche
      • 10.2.1 Hoffmann La Roche Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.2.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.2.5 Hoffmann La Roche Recent Development
    • 10.3 Bayer Healthcare
      • 10.3.1 Bayer Healthcare Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.3.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.3.5 Bayer Healthcare Recent Development
    • 10.4 Eli Lilly
      • 10.4.1 Eli Lilly Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.4.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.4.5 Eli Lilly Recent Development
    • 10.5 Johnson & Johnson
      • 10.5.1 Johnson & Johnson Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.5.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.5.5 Johnson & Johnson Recent Development
    • 10.6 Bristol-Myers Squibb
      • 10.6.1 Bristol-Myers Squibb Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.6.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.6.5 Bristol-Myers Squibb Recent Development
    • 10.7 AbbVie, Inc.
      • 10.7.1 AbbVie, Inc. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.7.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.7.5 AbbVie, Inc. Recent Development
    • 10.8 Gilead Sciences
      • 10.8.1 Gilead Sciences Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.8.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.8.5 Gilead Sciences Recent Development
    • 10.9 GlaxoSmithKline Plc
      • 10.9.1 GlaxoSmithKline Plc Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.9.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.9.5 GlaxoSmithKline Plc Recent Development
    • 10.10 Merck & Co., Inc.
      • 10.10.1 Merck & Co., Inc. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Sexually Transmitted Diseases (STDs) Drug
      • 10.10.4 Sexually Transmitted Diseases (STDs) Drug Product Introduction
      • 10.10.5 Merck & Co., Inc. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Sexually Transmitted Diseases (STDs) Drug Sales Channels
      • 11.2.2 Sexually Transmitted Diseases (STDs) Drug Distributors
    • 11.3 Sexually Transmitted Diseases (STDs) Drug Customers

    12 Market Forecast

    • 12.1 Global Sexually Transmitted Diseases (STDs) Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Sexually Transmitted Diseases (STDs) Drug Sales Forecast by Type
    • 12.3 Global Sexually Transmitted Diseases (STDs) Drug Sales Forecast by Application
    • 12.4 Sexually Transmitted Diseases (STDs) Drug Forecast by Regions
      • 12.4.1 Global Sexually Transmitted Diseases (STDs) Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Sexually Transmitted Diseases (STDs) Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Sexually Transmitted Diseases (STDs) Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sexually Transmitted Diseases (STDs) Drug.

      This report studies the global market size of Sexually Transmitted Diseases (STDs) Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Sexually Transmitted Diseases (STDs) Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Hoffmann La Roche
      Bayer Healthcare
      Eli Lilly
      Johnson & Johnson
      Bristol-Myers Squibb
      AbbVie, Inc.
      Gilead Sciences
      GlaxoSmithKline Plc
      Merck & Co., Inc.

      Market Segment by Product Type
      Chlamydia
      Gonorrhea
      Syphilis
      Genital herpes
      HPV
      HIV / AIDS

      Market Segment by Application
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Sexually Transmitted Diseases (STDs) Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Sexually Transmitted Diseases (STDs) Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Sexually Transmitted Diseases (STDs) Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now